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ANALYSIS OF MEFV GENE ALTERNATIVELY SPLICED TRANSCRIPTS 
EXPRESSION PATTERNS IN CELL CULTURE MODELS 
SUMMARY 
Familial Mediterranean Fever (FMF)  is an autoinflammatory disease of our region with a 
frequency of 1/200 to 1/1073. Main symptoms include periodicly recurrent fever attacks with 
painful inflammation in peritoneum, pleura, synovium and pericardium. These FMF attacks 
may result as amyloid formation and aggregation, if not treated, aggregation may lead to renal 
failure. The gene of FMF is MEFV, in which to date more than 200 variations were identified 
in patients. Although hereditary mode of inheritance of FMF was accepted as autosomal 
recessive, dominant or compound heterozygous cases as well as patients without any MEFV 
pathological mutations were identified. Furthermore there is evidence of MEFV involved in 
other inflammatory immune diseases such as Behcet syndrome, Crohn’s Disease and Gut.  
MEFV gene is an inflammatory/regulatory gene, codes for Pyrin/Marenostrin (P/M) protein.  
P/M is involved in inflammatory pathway through  interacting with pro-inflammatory 
elements, forms a part of the “inflammasome” complex. Inflammasome assembled in the 
cytoplasm causes the secretion of proinflammatory cytokines and leads to inflammatory 
response. MEFV gene is transcripted in several alternatively spliced forms. The most common 
MEFV protein isoforms  found in peripheral blood leukocytes and synovial fibroblasts are 
MEFV-8ext (additional extension of exon 8), MEFV-4a (lacking exon 5, 6, 7, 8, 9 and 10, 
with the addition of part of exon 4), MEFV-2a (with part of indicated exon) and MEFV-2Δ 
(exon 2 deleted transcript). Especially exon 2 is thought to be important in localization 
estimation.  It was shown that, deletion of exon 2, leads to localization errors even if the 
localization signals exist in the environment . Previous study of our group indicated that 
MEFV-2Δ is expressed higher in FMF cases rather than healthy controls (p= 0.026) in total 
blood samples.These findings leaded to the assumption that there can be a connection between 
inflammatory pathway and MEFV-2Δ transcript levels.  
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Our main hypothesis is to test the exact role of MEFV in inflammatory pathways. To 
understand the relationship, first we designed an inflammation model with primary human 
peripheral blood leukocyte (PBL) cell culture. We used lipopolysaccharide (LPS) induction 
to model inflammation and measured inflammatory cytokine levels. Our initial findings 
indicated a low cytokine levels in primary cell culture model. Therefore we constructed 
another inflammation model with HL-60 premyelocytic cell line cells. LPS induction of 
Phorbol 12-myristate 13-acetate (PMA) treated HL-60 cells produced excess amount of 
proinflammatory cytokine interleukin 1-beta (IL-1β).  
We further compared MEFV-2Δ expression with oher alternatively spliced transcripts in 
synovial fluid and blood samples of FMF patients in their attack period. To do this, we isolated 
RNA molecules from the samples and applied Reverse Transcription Polymerase Chain 
Reaction (RT-PCR) in combination with Quantitatvie Real Time PCR (QRT-PCR). Due to 
MEFV-2Δ’s being a rare product in all other RNA molecules, two different cDNA synthesis 
strategies were applied and compared to detect the accurate relative amounts of MEFV-2Δ 
and other MEFV transcripts. These strategies were cDNA synthesis with random priming and 
cDNA synthesis with target specific priming of MEFV aternatively spliced transcripts. We 
checked inflammation status with pro-IL-1β and TNF-α mRNA levels in each set up and we 
compared MEFV alternatively spliced transcript levels in stimulated versus untreated cells, 
additionally in synovial fluid and blood samples of FMF cases. We constructed inflammation 
model  succesfully with LPS induction after phorbol 12-myristate 13-acetate (PMA) 
differentiation. Furthermore, target specific cDNA synthesis resulted more accurately than 
random primed cDNA synthesis. Ct values of randomly primed MEFV alternatively spliced 
form cDNAs were around 40, while target specifically primed cDNA Ct values were in 
interval of 20-25 especially in inflammation cases.  
In conclusion, our findings indicated that MEFV-2Δ is highly expressed  in inflammation 
conditions (in inflammation model p=0.024; in synovial fluid samples p=0.037), and this 
transcript may have a putative function in inflammatory pathway and in FMF pathology.This 
result was confirmed with acute FMF synovial fluid and blood  samples and the hypothesis of 
MEFV-2Δ transcript’s being important for inflammatory pathway was supported. Further 
studies are required in higher number of patients during attack and remission periods, as well 
proteins interacting with MEFV-2Δ isoform and fulllenght pyrin need to be identified.  
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HÜCRE KÜLTÜRÜ MODELLERİNDE MEFV GENİ ALTERNATİF KIRPILMIŞ 
TRANSKRİPTLERİNİN EKSPRESYON MODELLERİNİN ANALİZİ 
ÖZET 
Ailevi Akdeniz Ateşi (AAA), bölgemizdeki görülme sıklığı 1/200 ila 1/1073 arasında olan 
otoenflamatuvar bir hastalıktır. Temel semptomları, periyodik olarak tekrarlanan ağrılı  karın 
zarı, akciğer zarı, eklem sıvısı ve kalp dış zarı enflamasyonlarıdır. Bu ataklar sonucu 
“amiloid” denilen protein çökeltilerinin oluşma olasılığı yüksektir, tedavi edilmezse amiloid 
birikimi böbrek yetmezliğine bağlı olarak ölüme sebebiyet verebilir. FMF hastalığıyla ilintili 
olan gen MEFV olup  FMF hastalarında bu genin 200’den fazla varyasyonu tanımlanmıştır. 
FMF hastalığının kalıtım modeli otozomal resesif olarak kabul edilmesine rağmen bazı 
durumlar baskın geçişli ya da bileşik heterozigot geçişli olarak raporlanmış olup, bazılarında 
hiç mutasyon gözlenmemiştir. MEFV geni enflamatuvar/regülatör gen olup 
“Pyrin/Marenostrin (P/M)” adı verilen bir proteini kodlar. P/M, pro-enflamatuvar elementlerle 
etkileşim halinde enflamazom kompleksinin bir parçasını oluşturarak enflamasyon yolizine 
dahil olur. Bununla birlikte MEFV geninin Behcet Sendromu, Crohn’s hastalığı ve gut gibi 
diğer otoenflamatuvar hastalıklarla  da ilgili olduğu kanıtlanmıştır.  
Alternatif kırpılma, transkripsiyon aşamasında gen ekzonlarının farklı sıralarda birleştirilmesi 
sonucu aynı genden türetilmiş çeşitli protein izoformlarının oluşmasını sağlayan bir süreçtir. 
“Anlamsızlık aracılıklı yıkım (AAY)” adı verilen bir mekanizma ile birlikte alternatif 
kırpılma, gen ekspresyonu ve protein üretiminin düzenlenmesi ve çeşitli protein yapılarının 
evrilmesi süreçlerinin bir parçasıdır. Aynı genden üretilen çeşitli protein izoformlarından, 
hücre gelişim seviyesine göre işlevsel olmayan protein AAY aracılığıyla parçalanır. Hücrede 
bu mekanizmalar, ihtiyaç duyulan proteinin üretilmesinde düzenleyici olarak işlev görür. 
Kompleks hastalık patofizyolojilerinde önemli bir rol oynadığı düşünülen bu süreçler, aynı 
zamanda gelişimsel farklılaşma yolizlerinde de oldukça etkin bir rol üstlenir. Alternatif 
kırpılmanın kanser, Parkinson, Alzheimer ve Kistik fibrozis gibi hastalık patolojilerinde 
görülen moleküler etkileşimlerde önemli rolü bulunduğu bilinmektedir.  
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MEFV geni transkriptleri çeşitli alternatif kırpılmış formlarda üretilmektedir. Özellikle 
lökositlerde ve eklem sıvısında en yaygın olarak gözlenen MEFV alternatif kırpılmış formları 
şunlardır:  MEFV-8ext (8. ekzonun ek bir kısmını içeren izoform), MEFV-4a ( 5, 6, 7, 8, 9 ve 
10. ekzonları içermeyen, 4. ekzonun bir kısmını içeren form), MEFV-2a (2. ekzonun bir 
parçasını içeren form) ve MEFV-2Δ (2. ekzonu içermeyen transkript). MEFV geninin 2. 
ekzonunun proteinin lokalizasyon tayininde önemli rol oynadığı düşünülmektedir. 2. ekzonun 
delesyonunun, ortamda nükleer lokalizasyon sinyalleri bulunmasına rağmen molekülün hatalı 
lokalizasyonuna yol açtığı bilinmektedir.  Grubumuzca yapılan bir çalışmada da  MEFV-2Δ 
izoformunun FMF hastalarında sağlıklı kontrollere göre daha yüksek oranda bulunduğu 
gösterilmiştir (p=0,026). Bu buluntular, enflamasyon yolizi ile MEFV-2Δ izoformunun 
ekspresyon seviyesi arasında bir bağlantı olasılığını işaret etmektedir.  
Gen ekspresyon seviyesi belirleme ve karşılaştırma çalışmalarında sıklıkla kullanılan 
yöntemlerden biri ters transkripsiyon - relatif kantitasyondur. Bu tip çalışmalarda, öncelikle 
örneklerden RNA izolasyonu yapılır ve RNA’dan, ters transkripsiyon polimeraz zincir 
reaksiyonu ile komplementer DNA sentezlenir. Komplementer DNA sentezi için rastlantısal 
primerler, “oligo-dT” primerleri veya hedefe özgü dizayn edilmiş primerler kullanılabilir. Bu 
üç yöntemden rastlantısal primerler ve oligo-dT primerleri, izole edilmiş RNA havuzu içinden 
herhangi bir RNA’ya bağlanarak hedef gözetmeksizin reaksiyon sonunda karışık bir 
komplementer DNA içeriği oluşmasını sağlarlar. Hedefe özgü primerler ise belirli bir RNA 
molekülüne bağlanarak özellikle bu RNA’ya ait bir komplementer DNA sentezini sağlarlar. 
Rastlantısal ve oligo-dT primerleri, tek reaksiyon ile birden fazla çeşitte komplementer DNA 
sentezine olanak verirken hedefe özgü primerler, bir reaksyonda tek tip komplementer DNA 
sentezini sağlar. Hedefe özgü primerler ile nadir olarak üretilen bir transkriptin tespiti 
sağlanabilir. Literatürde yer alan çalışmalarda, gen havuzu içinde nadir olarak üretilen 
transkriptlerin tespitinde hedefe özgü primerlerin daha doğru sonuç verdiği belirtilmiştir.  
Çalışmamızın temel hipotezi enflamatuvar yolizlerinde MEFV’in kesin rolünün 
belirlenmesidir. Enflamasyonda MEFV geninin rolünü anlamak için öncelikle insan primer 
lökosit kültüründe bir enflamasyon modeli tasarladık. Lökositleri aktive etmek için 
lipopolisakkarit (LPS) kullandık ve sonuç enflamatuvar sitokin seviyesini ölçtük. İlk 
buluntularımız primer kültür enflamasyon modelinde düşük sitokin seviyesini 
göstermekteydi. Bunun üzerine HL-60 premiyelotik hücre hattı hücrelerini kullanarak başka 
bir enflamasyon modeli hazırladık. Sonuç olarak Forbol 12-miristat 13-asetat (PMA) 
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uygulanmış HL-60 hücrelerinin LPS ile uyarımı, proenflamatuvar bir sitokin olan  İnterlökin 
1-beta (IL-1β)’nın yüksek oranda üretimine yol açtı. 
Daha sonra, MEFV-2Δ üretimini atak dönemindeki AAA hastalarının eklem sıvısı ve kan 
örneklerindeki diğer transkriptlerle karşılaştırdık. Bunun için örneklerden RNA izolasyonunu 
gerçekleştirdikten sonra Reverse Transkripsiyon Polimeraz Zincir Reaksiyonu (RT-PCR) 
yöntemini Kantitatif Gerçek Zamanlı Polimeraz Zincir Reaksiyonu (Q-RT PCR) yöntemi ile 
birlikte kullandık. MEFV-2Δ transkriptinin diğer RNA’lar içinde nadir üretilen bir ürün 
olması sebebiyle, ekspresyon profilinin doğru karşılaştırılabilmesi için iki farklı cDNA sentez 
stratejisi uyguladık. Bu stratejiler MEFV alternatif kırpılmış transkriptlerinden rastlantısal 
primerler ile komplementer DNA(cDNA) sentezi ve hedefe özgü primerler ile cDNA sentezi 
idi.  Enflamasyon durumunu deneyin her bir basamağındaki enflamatuvar sitokinler pro-IL-
1β ve Tumor Necrosis Factor-Alpha (TNF-α) üretimi seviyesiyle ve sağlıklı kontrollerle 
karşılaştırdık. Enflamasyon modelini PMA ve LPS uygulanmış hücrelerde başarı ile 
gerçekleştirdik. Ayrıca hedefe özgü primerler ile sentezlenen cDNA’lar ile rastlantısal 
primerlerle sentezlenmiş cDNA’lara göre daha doğru sonuçlar alınmıştır. Buna göre hedefe 
özgü primerlerle sentezlenmiş cDNAnın  taslak DNA olarak kullanıldığı durumda, gerçek 
zamanlı PCR’da referansa göre belirlenen eşik değer floresan sinyalinin aşıldığı döngü sayısı 
(Ct) ortalama 25 iken rastlantısal primerle sentezlenmiş cDNA’nın taslak olarak kullanıldığı 
reaksiyonlarda bu değerler ortalama 40 olarak bulunmuştur. 
Sonuç olarak, enflamasyon durumunda diğer transkriptlerin ekspresyon seviyesinin 
düşmesine rağmen MEFV-2Δ transkriptinin ekspresyonunun arttığı gözlenmiştir 
(enflamasyon modelinde p=0.024, sinoviyal sıvı örneklerinde p=0.037). Bu artış, özellikle 
hedefe özgü primerlerle yapılan sentezlenmiş komplementer DNA karşılaştırmalarında 
belirgin olarak gösterilmiştir. Enflamasyon ile paralel olarak gözlenen MEFV-2Δ ekspresyon 
artışı akut FMF durumundaki hastaların sinoviyal sıvı ve kan örneklerinden alınan sonuçlarla 
doğrulanmış olup, MEFV-2Δ transkriptinin enflamatuvar yolizinde önemli bir rolü 
olabileceği hipotezi desteklenmiştir. Daha yüksek sayıda hasta örneklemesi ile MEFV-2Δ 
izoformu ve pyrin ile etkileşen proteinlerin tanımlaması çalışmanın daha sonraki basamakları 
için gereklidir. 
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1. INTRODUCTION 
1.1 Mediterranean Fever Gene (MEFV) and Familial Mediterranean Fever (FMF) 
MEFV (Mediterranean FeVer) gene was identified in 1997 as the gene related with FMF. It 
is located in the short arm of 16th chromosome (Figure 1.1). Its position was defined by 
positional cloning (position of 13.3, between base pairs of 3,232,028 - 3,246,627) [1]. MEFV 
gene is known as an inflammatory regulatory gene. MEFV contains 10 exons and encodes  
“Pyrin/Marenostrin (P/M)”. There are more than 200 variants of MEFV gene to date, which 
are related to FMF. Some of the mutations are deletion mutations, but the most effective ones 
are missense or frameshift mutations [2]. In FMF cases; M694V,  V726A,  M694I, M680I in 
exon 2 and E148Q in exon 10 are most frequent mutations. MEFV mutations may lead to 
production of malformed or reduced levels of P/M. Loss of function of P/M protein results as 
inappropriate or prolonged inflammations [3].  
 
Figure 1.1 : MEFV gene sequence variants determined until 06.11.2013, retrieved from Infevers:  
an online database for autoinf. mutations (http://fmf.igh.cnrs.fr/ISSAID/infevers/) [4].  
Familial Mediterranean Fever (FMF) is a hereditary autoinflamatory condition which is 
characterized with periodicly recurrent fever attacks with painful inflammation in peritoneum, 
pleura, synovium and pericardium. Mediterranean populations (Turk, Arab, Armenian, and 
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Sephardic Jewish) are especially affected with the disorder. FMF attacks may result as 
amyloid formation and aggregation, if disease is not treated, it may lead to renal failure. Only 
effective treatment currently is colchicine against amyloid formation; however, it has serious 
side effects. Although hereditary penetrance pattern of FMF was accepted as autosomal 
recessive, some cases are reported as dominant or compound heterozygous and there are 
patients without MEFV have no mutations. The presence of FMF patients without major 
MEFV mutations indicate an involvement of other genetic or epigenetic mechanisms in FMF 
etiology [5]. 
1.1.1 MEFV Gene Expression and Alternatively Spliced Transcripts 
Alternative Splicing is the process of reconnection of exons in different ways. At the end of 
the splicing, several different products form from the single gene. In human, over 80% genes 
are alternatively spliced as a part of natural transcription process [6].  
MEFV is primarily expressed in white blood cells (especially in monocytes, neutrophils and 
eosinophils), synovial fibroblasts and dendritic cells [7]. MEFV expression is increased by 
pro-inflammatory agents such as Interferon γ (IFN-γ), Tumour necrosis factor α (TNF α), 
lipopolysaccharide (LPS) and Interleukin 1-beta (IL-1β). MEFV expression leads to increase 
in leukocyte level through inflammatory regulation [8]. 
MEFV has several alternatively spliced forms. The most common transcripts found in 
peripheral blood leukocytes and synovial fibroblasts are (Figure 1.2) exon 8ext (an extension 
of exon 8), exon 4a (lacking exon 5,6,7,8, 9 and 10, with the addition of part of exon 4), exon 
2a (with part of indicated exon) and exon 2Δ (exon 2 deleted transcript) [2]. MEFV-2Δ 
isoform is expressed in leukocytes and translated as a 570 residues length protein. This product 
is located primarily in nucleus while the full-length form of (P/M) is located in cytoplasm. 
Exon 2 is thought contain a localization regulator since the deletion of this region leads to 
localization errors even in the presence of Nuclear Localization Signals (NLS) [9]. However, 
the nature and the mechanism of this regulation is still unknown. 
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    Figure 1.2:Alternatively spliced transcripts of MEFV gene in PBL  
                                                 and Synovial Fibroblasts   [adapted from 2]. 
1.1.2 MEFV product: Pyrin (P/M) and protein isoforms  
MEFV expression patterns are important in the pathophysiology of FMF. As it is stated in the 
study of Grandemange et.al, beside the regular full-length P/M protein, there are several 
protein isoforms of P/M especially in leukocytes, translated from alternatively spliced 
transcripts of the MEFV gene. These forms are thought to be localized in different sub-cellular 
compartments according to their functions in inflammatory pathway [10]. The study indicated 
that MEFV expression is regulated post-transcriptionally via the mechanism of Nonsense 
Mediated Decay (NMD). According to the study, MEFV-fl, MEFV-2Δ and MEFV-2a (Figure 
1.2) is not subject of NMD and they form as protein isoforms. However especially transcripts 
that containing -4a are degraded via NMD. Transcripts that containing -8ext are regulated in 
a cell specific way; they are degraded in monocytes but not in neutrophils [10].  
Complete P/M molecule has five functional domains (Figure 1.3). N-terminal (P/M) domain 
captivating 1-95 residues (alternative names are: DAPIN, PYD, PAAD), bZIP transcription 
factor basic domain (residues 266-280), B-Box zinc finger domain (375-407), α-helical 
(coiled coil) domain (408-594) and C terminal B30.2 domain (also known as PRYSPRY) 
(598-774) [11].   
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Figure 1.3 : P/M molecule and domain interactions [8]. 
The most important mutations are generally affecting B30.2 domain, where (P/M) interacts 
with caspase-1 [8]. These mutations found to be related with other inflammatory diseases such 
as Behcet’s disease, Rhematouid arthiritis and inflammatory bowel disease (IBD) [12].  
According to the study of Ustek et.al. low mRNA levels of MEFV is related to FMF [11]. 
Notarnicola et.al. also showed the relationship between mRNA level of MEFV gene and 
MEFV mutations. According to the results, M694V mutations seen in FMF patients is 
associated to low MEFV expression levels [4]. However in the study of Booty et.al. MEFV 
expression was slightly higher in FMF patients than healthy people [15]. 
1.2 Pyrin (P/M) and Inflammation  
(P/M) associates Apoptosis-associated Speck-like Protein (ASC), adaptor molecule of 
inflammasome (Figure 1.4). It has PYD domain at its N-terminal, that interacts with (P/M)   
and CARD domain at C-terminal which associates with caspase-1. Activated caspase-1 induce 
the production of cytokines IL-1β, IL-18, IL-33, which results in interaction with ASC. The 
other activities of (P/M) is thought to be maturation of IL-1β and activation of NF-κB to 
regulate caspase-1 [11].  According to the study of Chae et.al, the wild type (P/M) domain of 
B30.2 interacts the inflammasome subunits of p20 and p10, which prevent these two 
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molecules to form a heterodimeric assembly after interaction. However, in FMF condition 
mutant (P/M) cannot interact with these molecules that would recruit assembling of them and 
this p20/p10 heterodimer induces IL-1β activation that may result as inflammation. This active 
heterodimer than cleaves (P/M) at Asp330 that is located between B-box zinc finger domain 
and bZIP basic domain. After cleavage N-terminal, cleaved part of the (P/M) interacts with 
p65 and other inflammation inducing factors while second part is interacted NF-κB in terms 
of inducing expression of inflammatory genes [8].  
 
Figure 1.4 : P/M and Inflammation [5]. 
It is shown that expression of (P/M) or its corresponding disease-associated mutants could 
induce ASC oligomerization and activation of caspase-1, but not NF-κB. On the other hand 
(P/M)-ASC interaction for caspase-1 activation is still unclear since MEFV knock-out mice 
has not been done to our knowledge [13].  
FMF pathogenesis was thought to be based on mutation, but new studies revealed that it is not 
completely mutation oriented.  On the other hand deficiency of relevant studies and samples 
in the studies, it is hard to come to an accurate conclusion. 
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1.3 Establishment Of Long Term Cell Culture and Inflammation Modelling 
Cell culture is the process of controlled growth of the certain type of cells in appropriate 
environmental conditions. To understand the features and processes of in vivo systems, in vitro 
model with cell culture systems are used. Cell culture can be established from primary cells 
(the cells that directly isolated and cultured from any organism) or leukemic (infinitely 
proliferating) cell lines [16]. 
Cultured cells need sterile environment with a stable pH and nutrients to grow and proliferate. 
Balanced salt solutions are minimal required media, defined for primary cell cultures and these 
solutions are commercially avaliable. These media is supplied with lipids, vitamins, amino 
acids and fatty acids to sustain the culture. Each cell type has special needs of medium contents 
and optimization is needed to establish long-term culture of desired cell type [16]. 
Primary cell culture establishment is a process, which has limitations of providing purity of 
the desired cell type, vitality and proliferation without difference in culture characteristics. 
Since primary cells are quietly fragile, it is needed use of growth factors and some other 
supplementary chemicals to maintain culture for long term [16]. 
Peripheral blood leukocytes are the cells, which are the parts of inflammation process. These 
cells express inflammatory regulatory MEFV gene transcripts and take part in inflammation 
actively. Pathogens or external molecules are recepted as pathogen associated molecular 
patterns (PAMPs). They  stimulate inflammatory pathway and lead to cytokine production 
[13]. Lipopolysaccharide (LPS) is one of the stimulatory factors (Figure 1.5). This molecule 
is produced from inner membrane of Gram-negative bacteria (e.g. E.coli) and recruits 
inflammatory assembly formation: inflammasome  and cytokine secretion [17].  
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Figure 1.5 : LPS structure and inflammation [17]. 
Another cell culture type is infinite cell culture with leukemic cell line cells. The 
promyelocytic leukemia cell line HL60 is one of the most used cell type for inflammation 
studies. It is possible to differentiate these cells into macrophage-like cells by stimulating them 
with the chemical called Phorbol 12-Myristate 13-Acetate (PMA) or into granulocytic cells 
by incubating them with Retinoic Acid (RA) [18].  PMA affects cells with activation of 
Protein kinase C that leads to production of transcription factors [19]. Retinoic acid RA’s 
biochemical effects are unclear. RA binds to specific nuclear receptors (RAR) and RA-RAR 
complex regulates target gene transcription, which are key regulators for differentiation [16].  
Immune system is recruited with pathogen associated molecular patterns such as 
lipopolysaccharide (LPS) and this recruitment activates inflammatory pathway (Figure 1.6) 
[11]. 
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Figure 1.6 : PAMP and Inflammation [11]. 
PAMPs interact with B30.2 domain of Pyrin and URR domain of Cryopyrin (Fgure 1.6). Both 
of these interactions lead to ASC oligomerization process and inflammasome assembly. 
Inflammasome formation recruits cytokine production such as Pro-IL-1β, it is formed as IL-
1β after maturation. Inflmmation is a general term of cytokine activity [11]. 
Inflammation status of the cells can be detected with inflammatory cytokine mRNA levels in 
the culture or tissue. The most common cytokines produced in inflammatory pathway are 
interleukin 1-beta (IL-1β) and tumor necrosis factor-alpha (TNF-α). These cytokines are 
commonly used as inflammation markers in molecular biology experiments [11]. 
1.4 Reverse Transcription Polymerase Chain Reaction (RT-PCR) and Complementary 
Deoxyribonucleicacid  (cDNA) Synthesis Strategies 
The most common RNA expression level detection method is Reverse Transcription 
Polymerase Chain Reaction (RT-PCR). In this technique, isolated RNA is converted into 
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double stranded complementary DNA (cDNA) with the activity of reverse transcriptase 
enzyme. cDNA is conventionally synthesized by using random (oligo-dT) primers. These 
primers match with poly-A tail of each RNA randomly. Finally a pool is constructed with 
randomly synthesized cDNA. Other priming strategies include use of hexamers or target 
specific primers [22].  
In relative quantitaton studies, random oligo-dT primers are preferred because of the ability 
of synthesizing plenty different cDNAs in one reaction with these primers. In target specific 
priming, only one type of cDNA (specific sequence) is synthesized and to compare relative 
amounts with other RNA expressions, single specific reactions are needed. In the study of 
Deprez R. H. it is  revealed that, expression analysis with target specific cDNA synthesis 
results are more accurate and sensitive than other priming strategies, especially for rare 
transcripts [23]. Since gene specific primers only bind to its complementary sequence, rare 
products can be captured from the pool as a result of the specific reaction. The rare product 
could possibly elimimated in the pool, however it is impossible to miss the rare product with 
gene specific priming. Target specific priming technique is uniplex, so to achieve a relative 
quantitation, the data should be normalized with a proper reference gene with the same 
reaction conditions and efficiency of the reactions should be took in consideration for proper 
computation [23]. 
1.5 Quantitative Real Time Polymerase Chain Reaction (QRT-PCR) 
Real Time Polymerase Chain Reaction is a technique that enables detection and quantitative 
analysis of targeted DNA molecule or molecules. The most important property of the 
technique is its providing the possibility of amplification detection in its “real time”, while it 
is occuring instead of determining quantity at the end [21]. To this purpose, detection is 
provided by monitoring targets via two methods; first one is double-strand DNA dying with 
non-specific intercalating dyes (such as SYBR Green). The second one is hybridization based 
fluorescent labeled oligonucleotide consisting DNA probs which enables detection after 
hybridization with its complementary –target- DNA.  
In this study, Real Time PCR applied as combined with Reverse Transcription and with SYBR 
Green intercalating dye, in terms of determining expression analysis of spliced forms of 
MEFV and inflammation related cytokines (interleukin 1-beta  and tumor necrosis-alpha ) 
[24].  
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Intercalating dyes bind to all DNA molcules without regarding any specificity, this feature 
leads to detection of all DNA molecules in the samples which includes both target and non-
target items[25]. As amplification occurs intercalating dye binds to more amount of DNA 
which result as more fluorescent signals that show directly the amount of amplified DNA in 
the sample . Although using intercalating dyes is an effective way for estimating amount of 
amplified DNA molecules in a sample it is stil problematique these type of dyes’ being 
unspesific. Thus, the fluorescence signals may refer to unspecific-unwanted amplifications 
such as primer dimers[26].  
These type of reactions are done by adding dsDNA intercalating dye to the PCR mix which 
contains sample, at the beginning of the reaction. Then, the mix is run in a thermocycler. A 
reference to a standard dilusion is used for quantification of concentration. Each cycle, 
fluorescence signals are measured by a light detector and after detection is completed, 
achieved data is used in further analyses [27].  
Quantification is effectuated by plotting cycle number against fluorescent output on a 
logaritmic scale. The cycle that sample’s fluorescence passes above the determined treshold 
(cycle treshold (Ct)) is used for quantifying template amount. Final Ct values enables 
comparison of template amounts[28]. For quantifying relative gene expression, evaluated 
level of target cDNA is divided to a known amount of housekeeping gene’s cDNA which is 
approximately same in each tissue and condition. Finally two methods can be held for 
achieving result of quantification which are absolute and relative quantifications[29]. 
Absolute quantification is accurate number of target molecules existing in the sample while 
relative quantification gives information about levels (as folds of each other) of expression of 
interested genes according to each other, instead of direct measurement[30]. 
1.6 Aim Of The Study 
We previously obeserved an increased MEFV exon 2 deleted mRNA in FMF patients 
leukocytes compared to healthy controls, which led us to hypotesize exon 2 splicing may have 
a role in inflammation and FMF pathology [20]. To this end, here we aimed to construct an 
inflammation model in human PBL primary cell culture and HL60 cell line cell culture to 
detect and analyse MEFV alternative spliced forms expression levels in inflammatory  
conditions in vitro. We also examined the spliced form transcript levels in different tissues 
(blood and synovial fluids) of FMF patients during their inflammatory attack period. To 
understand the expression differences, two different in vitro inflammation models were 
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constructed with primary cell culture (peripheral blood leukocytes)  and HL-60 cells. LPS 
induction is used as inflammatory agent with and without PMA and RA.  For the consistency 
of the in vitro models with in vivo mechanisms, synovial fluid and blood tissues from FMF 
patients in their attack period were collected  to construct a comperative study. After total 
RNA isolation for each culture and tissues, random and target specific priming strategies were 
applied to the aim of detecting MEFV-2Δ expression, rare MEFV transcript. Finally 
Quantitative Real Time PCR analysis was done to detect expression levels of the transcripts. 
The results were analysed statistically with using SPSS program (v. 21) for student’s t test and 
chi-square analysis. 
  
12 
 
  
13 
 
 
2. MATERIALS AND METHODS 
2.1 Materials and Laboratory Equipment  
2.1.1 Used equipments  
The laboratory equipment used in this study listed in Appendix A. 
2.1.2 Used chemicals, enzymes, markers and kits  
The chemicals, enzymes, markers and kits used given in Appendix B with their suppliers.  
2.2 Methods 
2.2.1 Primary PBL cell culture  
To construct the long term cell culture, different culture media were used. Each medium was 
prepared with sterilized materials and filtered with 0,22μm sterile microfilter. Cells were 
incubated in sterile fresh medium containing flasks, in 37ºC incubator with %1 CO2. The 
culture was maintained by refreshment of the media for each 3 days.  
Counting of living cells was done with Trypan Blue method. Firstly, Trypan Blue solution 
was prepared by adding %0.4 Trypan Blue stain in PBS. Cells were diluted with Trypan Blue 
solution (1:1). 10µl from this homogenized mix was transferred on a haemocytometer to count 
cell number/ml. Cover slip was put on the haemocyometer. Number of the cells in the large 
square of haemocytometer was counted in light microscope.  
The cell count of sample was calculated using the formula:  
Average cell number of in the sample: 
count of the cells in large square of haemocytometer x dilution factor x 104.      (3.1) 
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2.2.1.1 Isolation of peripheral blood leukocytes from whole blood 
Whole blood samples for primary PBL culture collected from healthy volunteers. Pooled 
blood sample collection was diluted 1:1 using sterilized Dulbecco’s Phosphate-Bovine-Saline 
(PBS). 15 ml Biocoll Seperation Medium for each 25ml of diluted blood was used to formate 
density gradient for separation of the leukocytes from other blood layers. For this process, 
Falcon tubes (50ml) were used. First, 15ml of Biocoll was added to empty Falcon tube then 
25 ml of 1:1 diluted blood sample was added upon the Biocoll carefully without disturbing 
separation layer of two phases. The whole tube was centrifuged at 20°C, 2300 RPM for 15 
minutes. After centrifugation, leukocytes were collected as a “cloudy interphase” with 1000µl 
pipette into a new clean Falcon tube.     
10 mL of PBS were added upon collected leukocyte to wash the cells. Then tube was 
centrifuged for 5 minutes at 2300 RPM. This step was done twice, the final pellet was 
dissolved in the medium (5 mL) which will be used further and incubated in 37ºC incubator 
with %1 CO2.  
2.2.1.2 Cell culture medium preparation 
For the establishment of long term primary cell culture, different mixtures was prepared from 
literature. According to culture stability, the everlast culture medium ingredient was chosen 
to maintain the culture for the next stages of the study. 
Each medium content was prepared in sterile conditions and cell growth was provided in 
T25 flasks with refreshing media in each 3 days, in %1 CO2 incubator at 37º C.   
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Table 2.1 : Establishment of Long Term Primary PBL Culture. 
COMPONENT DMEM 
Med.  
RPMI 
Med. 1  
RPMI 
Med. 2  
RPMI 
Med. 3  
RPMI 
Med. 4  
RPMI 
Med. 5  
DMEM (mL) 79.79       
RPMI (mL)  133.2  150  100  135 120  
10% Horse 
Serum (mL) 
10       
10% Fetal 
Bovine Serum 
(mL) 
10  15  10 15  30 
HEPES (mg) 476.6       
Glutamine 
(mM) 
 4  4 4 4 4 
Penicillin/Sterp
tomycin (µL) 
100  300  300  200    
Non-essential 
aminoacids 
(µL) 
200    100    
2.2.1.3 Leukocyte activation with Lipopolysaccharide (LPS) stimulation 
For LPS Stimulation, PBL cells were transferred into 6-well plate (1ml culture/well), and plate 
was incubated for 24 hours. Then, different concentrations of LPS were added to each group 
(10ng/µl, 50ng/µl and 100 ng/µl). Each well was studied as triplicate. The cells were incubated 
for another 24 hour. Before / after each treatment, cell number of the wells were calculated 
with Trypan Blue method and total RNA isolation was done separately for each group.    
2.2.2 HL60 cell culture and LPS induction 
Since primary cell culture is quietly fragile, to maintain proliferation and healthy growth of 
the cells a more reliable cell culture was constructed with HL60 cell line cells. To obtain 
inflammation and MEFV expression relationship an inflammation program was applied to 
cells as indicated in the figure 2.1.   
 
Figure 2.1 LPS Induction of HL60 cells [32]. 
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After isolation from total blood, cells were incubated in proper medium for 18 hours before 
serum deprivation. For serum deprivation 18 hours incubated cells were centrifuged at 1000 
X g for 1 minute. The pellet was dissolved in serum free or %0.05 serum containing medium 
and culture was incubated for another 18 hours before LPS addition. Then the culture was 
stimulated with LPS and incubated for 24 hours. In the “Day 3” cells were harvested and RNA 
isolation was done separately for each group. 
2.2.2.1 HL60 cell differentiation 
HL60 cells differentiated into macrophage-like cells by stimulation with PMA (10 ng/ml) for 
5 hours before LPS addition induction. For differentiation into granulocytic lineage, RA 
incubation was applied as in a concentration of 0.2nM for overnight before LPS addition. The 
same LPS induction protocol was applied as described above. 
2.2.2.2 Inflammation modelling with Lipopolysaccharide (LPS) induction of HL60 cells 
LPS Induction was applied according to the figure 2.1 with several different concentrations 
of LPS (10 ng/ml, 100 ng/ml, 1µg/ml, 10 µg/ml).  
2.2.3 Sample collection for FMF study 
To compare MEFV alternatively spliced forms expression levels, FMF patients synovial fluid 
and blood tissues were collected from Rheumatology Department of Cerrahpaşa University 
Medical Faculty. Each patient was in attack period of the disease. Healthy control samples 
were collected from other patients of the hospital who has no any inflammatory disease.  
Ethics Review Committee of Istanbul University Cerrahpaşa Medical Faculty approved the 
study. Consent form was obtained from each patient. Blood and synovial fluid samples were 
collected in 4 cc vacuum tubes containing EDTA and were kept at 4 °C for maximum two 
hours for prevention of RNA degradation.   
2.2.4 Total RNA isolation  
2.2.4.1 Total RNA isolation from cell culture 
Total RNA isolation from primary PBL and HL60 cell culture was done with High Pure RNA 
Isolation Kit (Roche). First, culture samples were transferred into 1.5 mL Eppendorf tubes. 
The tubes were centrifuged at 500 X g for 3 minutes and the supernatant was removed 
carefully. 200 µl PBS was added into white pellet and resuspended. Also 400 µl Lysis/Binding 
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Buffer was added and mixed by vortex for 15 seconds. The sample was transferred to filter 
tube and centrifuged at 8.000 X g for 15 seconds. After centrifugation, fluid was discarded. 
For each sample 90 µl DNase incubation buffer and 10 µl DNase I were mixed in a separate 
tube. The mixture was added into filter tube and incubated at room temperature for 15 minutes. 
After incubation, 500 µl Wash I Buffer was added into filter tube and centrifuged at 8000 X 
g for 15 seconds and the fluid were discarded. Then 500 µl Wash II Buffer was added into 
filter tube and centrifuged at 8.000 X g for 15 seconds and the fluid were discarded. 200 µl 
Wash II Buffer was added again into filter tube and centrifuged at maximum speed for 2 
minutes and the fluid was discarded with collection tube. The filter tubes were inserted 1.5 ml 
micro centrifuge tubes and 30 µl Elution Buffer was added. After incubation for 30 minutes 
in 4° C The tubes were centrifuged at 8.000 X g for 1 minute. The eluted RNAs were used for 
cDNA synthesis immediately since freeze-thaw action is degrading 60% of RNA.  
2.2.4.2 Total RNA isolation from whole blood 
Total RNA isolation from whole human blood was done by High Pure RNA Isolation Kit 
(Roche).  2 ml of Red Blood Cell Lysis Buffer was added to a sterile 1.5 ml reaction tubes. 
500 µl peripheral blood was added into tubes. The tubes were shaken at room temperature for 
10 minutes. Then the tubes were centrifuged at 500 X g for 5 minutes. After centrifugation, 
red supernatant was removed carefully with a sterile pipette. Again 1 ml Red Blood Cell Lysis 
Buffer was added to white pellet and mixed gently. The tubes were centrifuged again at 500 
X g for 3 minutes and the supernatant was removed carefully. 200 µl PBS was added into 
white pellet. Also 400 µl Lysis/Binding Buffer was added and mixed by vortex for 15 seconds. 
The sample was transferred to filter tube (spin column) and centrifuged at 8.000 X g for 15 
seconds. After centrifugation, fluid was discarded. For each sample 90 µl DNase incubation 
buffer and 10 µl DNase I were mixed in a separate tube. The mixture was added upon the 
filter tube. The tubes were incubated at room temperature for 15 minutes. After incubation, 
500 µl Wash I Buffer was added into filter tube and centrifuged at 8000 X g for 15 seconds 
and the fluid were discarded. Then 500 µl Wash II Buffer was added into filter tube and 
centrifuged at 8.000 X g for 15 seconds and the fluid were discarded. 200µl Wash II Buffer 
was added again into filter tube and centrifuged at maximum speed for 2 minutes and the fluid 
was discarded with collection tube. The filter tubes were inserted 1.5 ml microcentrifuge tubes 
and 30 µl Elution Buffer was added. After incubation for 30 minutes in 4° C. The tubes were 
centrifuged at 8.000 X g for 1 minute. The eluted RNA samples were used for cDNA synthesis 
immediately. 
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2.2.4.3 Total RNA isolation from synovial fluid 
Total RNA isolation from synovial fluid was done with High Pure RNA Isolation Kit (Roche). 
First, synovial fluid samples were diluted (1:1) with PBS. Diluted samples were transferred 
into 50 mL sterile Falcon tubes.  The tubes were centrifuged at 500 X g for 3 minutes and the 
supernatant was removed carefully. 200µl PBS was added into white pellet and resuspended. 
Also 400 µl Lysis/Binding Buffer was added and mixed by vortex for 15 seconds. The sample 
was transferred to filter tube and centrifuged at 8.000 X g for 15 seconds. After centrifugation, 
fluid was discarded. For each sample 90 µl DNase incubation buffer and 10 µl DNase I were 
mixed in a separate tube. The mixture was added into filter tube and incubated at room 
temperature for 15 minutes. After incubation, 500 µl Wash I Buffer was added into filter tube 
and centrifuged at 8000 X g for 15 seconds and the fluid were discarded. Then 500 µl Wash 
II Buffer was added into filter tube and centrifuged at 8.000 X g for 15 seconds and the fluid 
were discarded. 200 µl Wash II Buffer was added again into filter tube and centrifuged at 
maximum speed for 2 minutes and the fluid was discarded with collection tube. The filter 
tubes were inserted 1.5 ml microcentrifuge tubes and 30 µl Elution Buffer was added. After 
incubation for 30 minutes in 4°C. The tubes were centrifuged at 8.000 X g for 1 minute. The 
eluted RNA samples were used for cDNA synthesis immediately since freeze-thaw process is 
degrading 60% of RNA. 
2.5    Complementary DNA (cDNA) Synthesis 
Since RNA is a fragile molecule, to prevent degredation of RNA, complementary DNA 
(cDNA) synthesis was done immediately after isolation with reverse transcription polymerase 
chain reaction (RT-PCR) by using ABI High Capacity Reverse Transcription Kit®.  For cDNA 
synthesis two different priming strategies were used which are random priming and target 
specific priming. 
2.5.1 cDNA synthesis with random priming 
Master mix preparation: 2 µl of 10x RT Buffer, 0,8 µl of 25x dNTP Mix  (100 mM), 2 µl of 
RT Random Primers 1 µl of Reverse Transcriptase enzyme, 4,2 µl of Nuclease-free H2O per 
sample was added to compose a master mix. Then, 10 µl of the mix was distributed to PCR 
tubes and 10 µl RNA per tube was added for each PCR tube. (Final reaction volume is 20 µl). 
PCR tubes were transferred to a thermal cycler, the PCR program was edited as indicated in 
Table 2.2. 
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Table 2.2 cDNA Synthesis Reaction Protocol. 
Tempeature (°C) Time 
25 10 
37 120 
85 5 
4 ∞ 
2.5.2 cDNA synthesis with target specific priming 
Same reaction volumes and conditions were applied using the primer sets below, instead of 
random primers. Target specifically designed primers were used to detect each RNA 
expression in separate reactions.  
Table 2.3 : Oligonucleotide primer sequences. 
Oligonucleotide primer name Oligonucleotide primer sequence 
MEFV 1-3 Forward CAT TCA GGG AAG GCC ACC AG 
 
MEFV 1-3 Reverse TTC CTT TCA TGG GAG TCC TG 
MEFV 2-3 Forward 
 
GAA ATC CAG AAC ATT CGG TCA 
MEFV 2-3 Reverse ACC GTC AAC TGG GTC TCC TT 
MEFV 10 Forward GGA GGG AAG AAC ACA GCT CC 
 
MEFV 10 Reverse GGA GGG AAG AAC ACA GCT CC 
 2.6 Quantitative Real Time PCR MEFV Gene Expression Analysis  
The real – time PCR experiments was done by  using LightCycler ® 480 Master Kit (Roche) 
and performed at Roche LightCycler ® 480 instrument. Beta Actin gene was used as reference 
gene. 
Real Time PCR mix was prepared as indicated: 10μl of Roche Light Cycler 480 Real Time 
PCR Master mix, 1,25 μl of forward primer (10 µM) and 1,25 μl of reverse primer  (10 µM) 
were mixed for each sample that would be exposed to Real Time PCR application. 5,5 μl of 
dH2O  and 2 μl of template DNA (100 ng/µl)  were added.  
These samples transferred to light cycler and Real-Time PCR protocol was applied as 
indicated in the Table 2.4. 
Table 2.4 : Quantitative Real Time PCR Protocol. 
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Program Temperature (°C)  Time (min:sec) 
Pre-incubation 5           10:00 
Denaturation 95           10:00 
Annealing 59           00:30                  45 cycles 
Extension 72           00:01 
To check reaction specifity in SYBR-Green I based real time PCR reactions, melting curve 
analysis is used after real time PCR reaction.  
Table 2.5 : Quantitative Real Time PCR Protocol for Melting Curve Analysis.  
Temperature (°C) Time (min:sec) 
95 00:05 
65 00:05 
97 00:05 
40 00:30 
Specific oligonucleotide primers given in the table 2.6, were designed using Premier Biosoft 
primer designing software. MEFV 1-3 and 2-3 primers were designed to target exon-exon 
junction regions. MEFV 1-3 primer set captivates MEFV region which excludes exon 2. 
MEFV 2-3 primer set  was designed to captivate exon 2. MEFV 10 primer set binds to a 
specific region in exon 10, this set is designed to capture all other spliced MEFV transcripts 
since exon 10 is a common part of the spliced transcripts.  Interleukin 1β and TNF-α sets are 
specific to indicated cytokines. β-Actin primer set was used to detect β-Actin as reference – 
house-keeping gene.   
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Table 2.6 Oligonucleotide primer sequences. 
Oligonucleotide primer name Oligonucleotide primer sequence 
MEFV 1-3 Forward CAT TCA GGG AAG GCC ACC AG 
 MEFV 1-3 Reverse TTC CTT TCA TGG GAG TCC TG 
MEFV 2-3 Forward 
 
GAA ATC CAG AAC ATT CGG TCA 
 
MEFV 2-3 Reverse ACC GTC AAC TGG GTC TCC TT 
MEFV 10 Forward GGA GGG AAG AAC ACA GCT CC 
 MEFV 10 Reverse GGA GGG AAG AAC ACA GCT CC 
 
 
Interleukin 1β Forward GTC CTC AAT CTG CAC TCA ATC C 
Interleukin 1β Reverse TGA CAG GCG AGG CTA TCT CAG 
AAC β-Actin Forward C  GAG GAC TAT GAT TGC AC 
β-Actin Reverse TCC ATA AGC CGT CAT ACA TAT 
CA TNF-α Forward GCA GGC AGC CAG ATC ATC TGC 
TC TNF-α Reverse CGA GCT ACC CCT CTG ATT 
2.7 Relative Quantification and Statistical Analysis 
Relative Quantification was determined via comparative CT (ΔCT) method that calculates  
relative gene expression. This method was applied by substracting CT value of target gene 
from reference gene’s CT value. 
(CT of MEFV transcript- CT of Beta Actin Gene (ACTB))=ΔCT     (3.2) 
Then, this ΔCT value was exposed to “2-ΔCT” process to evaluate relative expressions. 
T value indicates the fold of expression that change between target gene (MEFV) and 
reference gene (Beta Actin). 
The 2-ΔCT value of FMF patients group and healthy control group were analyzed statistically 
by using Student’s t test, Chi square analyses using SPSS statistical analysis program (v.21). 
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3. RESULTS 
3.1 Primary Cell Culture Maintenance 
Primary cell culture maintenance success was evaluated according to the rate of vitality, 
proliferation and apperance of cells in the culture. According to these criteria, the results are 
summarized in the Table 3.1, Figure 3.1 and Figure 3.2.  
Table 3.1 : Primary PBL culture maintenance and characteristics. 
CELL
TYPE 
ISOLATN. 
METHOD 
MEDİUM VİTALİTY CELL CHARACT. 
PBL 
Density 
Gradient 
DMEM Medium: 
DMEM/HS/FBS/Glutamine 
PenStrep/ non essential aa 
mix/HEPES 
7-9 days 
Small cells, 
proliferation in low 
rate, cluster 
formation 
  
RPMI Medium 1: RPMI 
1640/Glutamine/PenStrep 
5-7 days 
Small cells, cluster 
formation 
  RPMI Medium 2: RPMI 
1640/10%FBS/Glutamine/PenStrep 
7-9 days 
Small cells, fast 
proliferation 
  
RPMI Medium 3: RPMI 
1640/Glutamine/PenStrep/aminoaci
d mix 
10-13 days 
Small cells, cluster 
formation 
  
RPMI Medium 4: RPMI 
1640/10%FBS/Glutamine/PenStrep 
7-9 days 
Small cells, 
proliferation in low 
rate 
  
RPMI Medium 5: RMI 
1640/10%FBS/Glutamine 
9-11 days 
Small cells, 
proliferation in low 
rate. 
  
RPMI Medium 6: 
RPMI1640/20%FBS/Glutamine/ 
10-12 days 
Small cells, 
proliferation in low 
rate. 
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RPMI Medium 3: Enriched RPMI 1640 medium with Glutamine, Penicillin-Streptomycin 
and non-essential aminoacid mix is the best medium for minimal primary PBL culture 
with long living cells, high proliferation rate and late formation of clusters (Figure 3.1 and 
Figure 3.2). 
 
Figure 3.1 : PBL primary cell culture vitality rates of different medium contents (days). 
The other medium contents leaded to fast cell death, low growth and proliferation profile. 
On the other hand, all culture apperance were similar, rare, small cells after isolation and 
after incubation, increase in cell number, dead cells in the culture with cluster formation  
(Figure 3.2) 
 
 
Figure 3.2 : Culture view right after isolation & after incubation (sample figure). 
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3.1.1 PBL culture MEFV alternatively spliced transcripts expression in terms Of LPS 
activation 
To understand inflammation and MEFV alternatively spliced forms expression relationship 
PBL culture was activated with LPS and MEFV alternatively spliced forms expression levels 
were detected with real time PCR method. Data analysis was done with Student’s t test. 
In the data figured (Figure 3.3), LPS (10) cells were incubated with 10 ng/µl LPS and LPS 
(100) cells incubated with 100ng/µl LPS. LPS-PM cells were incubated with a combination 
of 10 ng/µl PMA and100ng/µl LPS. Control / untreated cells were only exposed to serum 
deprivation.   
  
 
Figure 3.3 : LPS induced PBL MEFV alternative spliced transcripts expression levels. 
It is seen that an inflammation indicator TNF alpha expression is not statistically significant, 
due to LPS induction (p>0.05). On the other hand, MEFV 1-3 expression (MEFV-2Δ) is 
significantly higher than MEFV 2-3 expression (p<0.05).   
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3.2 HL60 Cell Culture Maintenance 
3.2.1 Cell vitality after PMA and LPS incubation 
According to literature review, PMA stimulation was done for different time intervals. PMA 
and LPS treatment effects to cell vitality is summarized in Figure 3.4 and Figure 3.5. 
 
Figure 3.4 : PMA Stimulation with LPS induction (simultaneously) effects on cell number           
of  the culture. 
The most destructive effect was observed with PMA application in cell vitality (5% cell  
vitality). To enhance PMA effect, PMA was applied 5 hours before LPS, and cell vitality was 
affected more than simultaneous incubation (Figure 3.5). 
 
Figure 3.5 : PMA stimulation before/in combination with LPS induction effects of cell   
number of the culture (PMA stimulation was applied 5h prior to LPS 
induction). 
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Since the desired inflammation profile is observed with prior PMA stimulation, next steps of 
the experiments were done with prior PMA stimulaton to LPS treatment. 
3.2.2 Quantitative Real Time PCR results of HL60 LPS induction 
HL60 cell culture MEFV expression was detected with two different strategies: random 
priming and target specific priming. According to results, LPS alone did not alter IL-1β 
production. However, it enhanced MEFV mRNA expression. On the other hand, LPS with 
PMA decreased MEFV other spliced forms expression but increased production of MEFV-
2Δ mRNA. The random priming and target specific priming results were summarized in 
figures 3.6 and 3.7. 
In the Figure 3.6, data schematized in logatitmic scale, LPS 10 refers to cells incubated with 
10 ng/µl LPS. PMA refers to cells incubated with 10 ng/µl PMA LPS 100: cells incubated 
with 100 ng/µl LPS.  LPS1000 cells incubated with 1000 ng/µl LPS.  LPS10000 cells 
incubated with 10000 ng/µl LPS.  LPS-PMA: cells incubated with a combination of 10 ng/µl 
PMA and100ng/µl LPS LPS 200: cells incubated with 200 ng/µl LPS.  LPS100+ATRA: cells 
incubated with 0.02 nM Retinoic acid and 100 ng/µl LPS. 
 
Figure 3.6 :MEFV alternatively splicing transcripts expression levels after LPS induction in 
                     HL60 cells / random priming. 
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It is seen that LPS-PMA combination leaded to expression of IL-1β RNA, inflammation 
indicator, in excess amount and significantly higher than untreated control sample. However, 
MEFV1-3  expression is not as high as expected.  
In the Figure 3.7, L100 refers to the cells incubated with 100 ng/µl LPS.  L200 shows the 
cells incubated with 200 ng/µl LPS.  LA cells were incubated with 0.02 nM Retinoic acid 
and 100 ng/µl LPS LP cells were incubated with a combination of 10 ng/µl PMA 
and100ng/µl LPS Control shows the untreated cells and RA treatment was incubation with 
only 0.02 nM retinoic acid . (p<0.5for L200, LA and LP) 
 
Figure 3.7 MEFV alternatively splicing forms expression levels after LPS induction in   
HL60 cells / target specific priming. 
It is observed in Figure 3.7, LPS treatment with high amounts leading to increase of  MEFV-
2Δ expression, but not for the other spliced forms that containinf exon 2 of MEFV. On the 
other hand the most dramatical increase is seen with LPS and PMA combination. Target 
specific primed cDNA data was more accurate and repeatable than random primed cDNA 
study. 
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3.3 MEFV Alternatively Spliced Transcripts Expression Comparison Of Synovial Fluid 
and Blood Tissues in Attack Period Of FMF Disease 
MEFV Spliced forms expression levels compared in blood and synovial fluid tissues of FMF 
patients. Again, two different cDNA synthesis strategies were applied to the cDNAs as 
random priming and target specific priming.  
Figure 3.8 shows seperate patient samples with the comparison of MEFV isoforms expression. 
(P2-Blood/Random: Acute FMF Patient no. 2-blood sample  P2-SF/Random: Acute FMF 
Patient no. 2-synovial fluid sample , P3-SF/Random: Acute FMF Patient no. 3-synovial fluid 
sample, P4-Blood/Random: Acute FMF Patient no.4-blood sample, P4-SF/Random: Acute 
FMF Patient no. 4-synovial fluid sample, template cDNA synthesized with Random priming). 
MEFV-2Δ expression is detected as less than other forms for each FMF patient in acute phase, 
in blood and synovial fluid. Also, IL-1β expression level is not as  high as expected. The 
results with random priming was different for each sample sets which indicates 
unrepeatability. 
 
Figure 3.8 MEFV alternatively splicing forms expression levels in FMF acute phase       
cases/random priming. 
Differently from random priming results The results of target specifically primed transcripts 
expression analysis revealed that, MEF-2Δ  expression is significantly higher than exon 2 
containing transcript levels as shown in the figures 3.9 and 3.10. 
In the figure 3.9, P1-Blood/T indicates the sample of acute FMF patient no. 1-blood sample.  
P1-SF/T  shows the same patient’s synovial fluid sample. Similarly, P2-Blood/T: Acute FMF 
Patient no. 2-blood sample  P2-SF/T: Acute FMF Patient no. 2-synovial fluid sample; P3-
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SF/T: Acute FMF Patient no. 3-synovial fluid sample, P4-Blood/T: Acute FMF Patient no.4-
blood sample, P4-SF/T: Acute FMF Patient no. 4-synovial fluid sample, for all of the data set, 
template cDNA synthesized with target specific priming.  (p<0.05 for P1, P2, P3, P4, p>0.05 
for P2) 
 
      Figure 3.9 : MEFV Alternatively Splicing Forms Expression Levels in FMF acute phase      
cases/target specific priming. 
In the figure 3.10 there is a general comparison of average expression levels of MEFV 
alternatively spliced transcripts. In this data the templates were synthesized with target 
specific priming. Figure indicates MEFV-2Δ expression  being higher than other transcripts 
of MEFV that contains exon 2. (*For both of blood and synovial fluid data sets p<0.05)  
  
Figure 3.10 : MEFV Alternatively Splicing Forms Expression Levels in FMF acute phase    
cases/target specific priming. 
These data reveals that, exon 2 lacking transcript of MEFV is abundantly expressed in 
inflammation cases and target specific priming is a suitable method to detect this rare 
mRNA expression levels. 
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4. DISCUSSION 
Since in our study, we wanted to determine inflammation parameters, using in vitro 
inflammation model; to construct a minimal culture medium was important. It was possible 
to elongate culture vitality with supplements like hydrocortisone and other growth factors, but 
it is known that, these materials have putative effects on molecular interactions of 
inflammatory pathway [16]. Thus the medium contents were chosen as providing the minimal 
needs as possible. Results indicated that the medium containing non-essential aminoacid mix 
with 10% FBS was the most suitable medium for primary PBL cell culture according to 
relatively less cluster formation and slow death rate of the cells than other media. This medium 
was chosen to be used further studies of inflammation model. 
Both in vitro inflammation model and synovial fluid sample study was designed to reveal 
MEFV-2Δ isoform expression pattern in inflammation cases. Alternative splicing is a process 
of reconnection of exons, known as a putative process in gene expression and also have 
important effects in complex disease pathophysiologies. It is a biological trade-off to arrange 
developmental differentiations.  Beside nonsense mediated decay (NMD), it also leads to 
evolution of preferred combinations of protein structures. Cells prefer to produce each 
alternatively spliced form as a regulatory mechanism whether it is useful or not for cellular 
activities. Unuseful molecules are degraded with NMD [9]. Also it is known that alternative 
splicing is involved in many disease pathogenesis such as cancer, Alzheimer’s Disease, 
Parkinson, Cystic Fibrosis [32]. Specifically MEFV alternative splicing is important in several 
disease pathologies such as Behcet’s syndrome, Chron’s disease and gut [9]. 
In practical applications of the designed experimental flow, it was hard to detect MEFV-2Δ 
mRNA since it is rarely produced relative to all other mRNA expression levels in leukocytes, 
synovial fluid and cultured cells. To detect this rare transcript, cDNA synthesis methods with 
random or oligodT priming were neither unreliable, inaccurate, nor repeatable. To reveal the 
expression rate relative to other spliced forms, we decided to use target specificly designed 
primers instead of random primers. After analysis, we compared both of expression detection 
patterns with each other for each data set. According to results, target specific priming, as 
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indicated in literature [23], is the most reliable method to detect rare products in real time PCR 
analysis. Expression of the MEFV alternatively spliced transcript MEFV-2Δ is rare, but it is 
increasing in inflammatory states(p=0.024 in HL-60 cells and p=0.037 in synovial fluid 
samples) as we have shown before (p=0.026) [36].  To detect the inflammation status of the 
samples, different cytokine mRNA expression levels such as TNF-alpha and Interleukin-1beta 
was evaluated. IL-1β amplification was shown in LPS+PMA treated HL-60 cells. Thus we 
can say the inflammation was succeeded with both LPS and PMA treatment, and inflammation 
triggers MEFV-2Δ production in HL-60 cells rather than the other alternative spliced forms 
of MEFV such as MEFV full length and other exon 2 containing transcripts. Our findings 
indicated that MEFV-2Δ is highly expressed in inflammation conditions, and this isoform may 
have a putative function in inflammatory pathway and in FMF pathology. This result was 
confirmed with acute FMF synovial fluid and blood  samples and the hypothesis of MEFV-
2Δ transcript’s being important for inflammatory pathway was supported. 
Furthermore importance of MEFV exon 2 in localization estimation is shown in a different 
study of our group. The study indicated that in neutrophil-like differentiated HL-60 cells and 
LPS/PMA treated HL-60 cells MEFV full length green flourescent protein (MEFV-fl-GFP) 
and exon 2 deleted MEFV isoform green flourescent protein (MEFV-2Δ-GFP) transcripts are 
located in the cytoplasm. However in non-treated HL-60 cells MEFV-fl-GFP was located in 
cytoplasm and MEFV-2Δ-GFP was in nucleus [33]. Combining this data with IL-1β increase 
being alongside with increase in MEFV-2Δ expression in inflammatory cases strengthens our 
hypothesis of MEFV-2Δ isoform’s impotant role in inflammatory pathway. To understand 
detailed role of MEFV-2Δ in inflammatory pathway and disease pathogenesis, further studies 
required with increased numbers of patient samples and additionally protein interaction 
comparisons of MEFV-fl and MEFV-2Δ isoforms.   
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APPENDICES 
APPENDIX A: Used Laboratory Equipments 
 
APPENDIX B: Used Chemicals and Kits 
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APPENDIX A: Used Laboratory Equipments 
 
Centrifuges     
Sigma 1-13 B. Braun International       
Allegra 25R Centrifuge Beckman Coulter  
 
Pipettes       
Gilson Pipetman 20 µL 200 µl, 1000 µl 
   
Spectrophotometer  
Thermo NanoDrop2000 
 
Thermal cycler      
Techne FTGENE 5D  
 
Light Cycler 
Roche Light Cycler 480 
 
Light Microscope 
Olympus CH30 
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APPENDIX B: Used Chemicals and Kits 
 
 
Chemicals: 
 
 
dNTP                                                             Fermentas, iNtRON Biotechnology  
Ethanol                                                          Riedel-de Hanen  
MgCl2                                                            Fermentas, iNtRON Biotechnology  
NaOH                                                             2008  
Primers                                                          IDT, Sentromer  
i-Taq DNA Polymerase                                iNtRON Biotechnology  
Tris Base                                                       Amresco  
10X PCR Buffer                                           Fermentas  
Taq DNA Polymerase                                     Fermentas 
 
Kits: 
cDNA Synthesis                                         High Capacity Reverse Transcription Kit           
(Applied Biosystems)       
DNA Isolation                                               DNA Isolation Kit from Mammalian  
                                                                        Blood       (Roche) 
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RNA Isolation                                               High Pure RNA Isolation Kit (Roche) 
Real-Time PCR                                            LightCycler 480 Master Mix (Roche) 
PCR        High Fidelity Polymerase Chain Reaction 
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